Understanding the functional importance of these complex, networking signaling pathways and their underlying mechanisms will shed light on helping to establish the potential specific, prime, and novel targets of RISP and associated signaling molecules for treating PH in COPD and other relevant diseases compared to the current non-specific medications. This evidence concerns the gene UQCRFS1 and chronic obstructive pulmonary disease.